Neuraxial Anesthesia for Labor and Cesarean Delivery in a Parturient With Hereditary Antithrombin Deficiency on Recombinant Human Antithrombin Infusion Therapy

Authors :: Alexander Wolfson
Alaeldin A. Darwich
Megan Rosenstein
Anup Pamnani
Source :: Obstetric Anesthesia Digest. 31:248-249
Publication Year :: 2011
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2011.
Abstract: A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor and cesarean delivery, is presented.

Full Text Access

Tools